The Pathway to Discovery
Anaxomics provides biopharmaceutical companies with the most advanced Systems Biology Technologies to help you improve your Drug Discovery and Drug Reprofiling research.
We work in the following domains:
Fully understand complex Mechanism of Action of drugs and combinations. learn more...
Early profiling of safety issues and off-target effects. learn more...
Finding new indications for existing drugs (drug reprofiling or repurposing). learn more...
In/Out license and investment evaluations (for partnering biopharmas and investors). learn more...
Required regulatory Predictive Medicine studies. learn more...
Solutions for Nutraceuticals and Cosmetics companies learn more...
We are committed to the discovery and development of new and better drugs to improve human health. Our goal is to help the biopharma industry to maximize the value of their discovery and clinical development by leveraging the potential indications of all the compounds on their pipeline, and by identifying and minimizing in their potential safety risks.
We are also establishing long-term partnerships with our clients to:
Identify new drug targets
Identify new Biomarkers
Identify molecular basis of mechanisms of action
Learn more about Integrated SolutionsAnaxomics Therapeutic Performance Mapping System©:
is a proprietary technology developed by Anaxomics that allows Biopharma companies to maximize the value of their pipeline by analyzing the safety profile of their drugs in the pipeline, and by finding new indications for known molecules
Learn more about Therapeutic PerformanceMapping System
News & Updates
Anaxomics to be present in the Bio-Europe Spring Conference in Barcelona Learn more...
Anaxomics in the Bio International Convention in ChicagoLearn more...
Anaxomics has been awarded 5 ner competitive research grants from the european union's seventh framework programme FP7-HEALTH-2013Learn more...
Anaxomics awarded by Red Herring as one of the 100 most innovative European companies. Learn more...
New publications added recently related to the use of systems biology in drug discovery Learn more...
Anaxomics launches the Global Collaborative Initiative for Drug Reprofiling. We are supporting biopharma companies to analyze and identify new indications for drugs already in the pipeline froma rational and highly predictive perspective, on a fee-for-service, or risk-sharing basis.
Learn more about Global Drug Reprofiling
Anaxomics is looking for partners for competitive public R&D multinational projects, both in Europe and North-America.
Learn more about Research and Development
Learn how Anaxomics can help Nutraceuticals and Cosmetics companies to comply withregulatory requirements and sustain scientific claims before regulatory agencies.
Learn more about Nutraceuticals and CosmeticsThe use of Therapeutic Performance Mapping System© allows Anaxomics' customers to find new potential cures for Alzheimer Disease.
Find more in this Video about Drug Reprofiling:Our company's locations
Lausanne
Mr Jaccard, Rte de Vallaire 5 B
1025 CH-Saint-Sulpice, Vaud
See it on Google maps
Phone: +34 93 451 67 17
info@anaxomics.com
Barcelona
c/Balmes, 89, 4º, 2ª
08008, Barcelona
See it on Google maps
Phone: +34 93 451 67 17
info@anaxomics.com
Boston
8, Faneuil Hall Marketplace
02109 Boston, Massachusetts
See it on Google maps
Phone: +34 93 451 67 17
info@anaxomics.com




